Haspin-IN-3

CAS No. 2416569-95-2

Haspin-IN-3( —— )

Catalog No. M35430 CAS No. 2416569-95-2

Haspin-IN-3 is a potent haspin inhibitor with an IC50 of 14 nM.Haspin-IN-3 has anticancer activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 102 In Stock
10MG 164 In Stock
25MG 281 In Stock
50MG 411 In Stock
100MG 551 In Stock
200MG 728 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Haspin-IN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    Haspin-IN-3 is a potent haspin inhibitor with an IC50 of 14 nM.Haspin-IN-3 has anticancer activity.
  • Description
    Haspin-IN-3 (compound 8l) is a potent haspin inhibitor with IC50 of 14 nM. Haspin-IN-3 has anticancer effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Haspin Kinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2416569-95-2
  • Formula Weight
    278.26
  • Molecular Formula
    C16H10N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (89.84 mM; Ultrasonic (<60°C)
  • SMILES
    Oc1ccc2C(=O)\C(Oc2c1)=C\c1c[nH]c2ncccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Malikotsi A Qhobosheane, et al. Synthesis and evaluation of 7-azaindole derivatives bearing benzocycloalkanone motifs as protein kinase inhibitors. Bioorg Med Chem. 2020 Jun 1;28(11):115468. ?
molnova catalog
related products
  • IXA4

    IXA4 is a highly selective, nontoxic activator of IRE1/XBP1s and reduces APP secretion by activating IRE1. IXA4-stimulated IRE1 activation also enhanced pancreatic function.

  • Ginsenoside Rs1

    Ginsenoside Rs1 is extracted from Panax ginseng root.

  • Hederagenin 3-O-(2-O...

    Hederagenin 3-O-(2-O-acetyl-α-L-arabinopyranoside) significantly increased alkaline phosphatase (ALP) activity and the level of protein expression of bone sialoprotein (BSP) and osteocalcin (OC) .